Another intriguing possibility is that the binding of the structural PrM and Env to PLG and CLU strengthen the already existing connectivity between the complement pathway and fibrinolytic activity at the interactome level [ 30, 31], via CLU-C7-PLG and CLU-PRNP-PLG, causing "oversensitivity" in the system.
These pathological findings indicate an association between hyperactivation of the complement pathway and development of the characteristic microstructures of PIG.
The classical complement pathway converges with the alternative and lectin pathways at the level of C3, from where effector functions of complement are generated.
Three biochemical pathways activate the complement system: the classical complement pathway, the alternative complement pathway, and the mannose-binding lectin pathway [14].
High ranking MetaCore pathways were "Classic complement pathway", "Lectin Induced complement pathway", and "Alternative complement pathway", based on complement and integrin genes such as C1QA, C1QB, C3, C3AR1, ITGAM, ITGAX, and ITGB2.
Activation of the complement cascade can be triggered via the alternative complement pathway and the mannose-binding lectin pathway.
These included the antigen presentation pathway, complement pathway, and IL1 and IL10 signalling pathways (data not shown).
AMD and the alternative complement pathway: genetics and functional implications.
An interesting link between the role of the alternative complement pathway factors ASP and C5L2 and immune and adipose have been supported by active demonstration of adipose tissue macrophage infiltration, apoptosis and tissue remodelling in obesity, and the differences demonstrated between HAT and LAT.
We show that antibodies raised against these PspC constructs are variant specific and prevent association between PspC and the complement pathway mediator, human factor H. We found that PspC variants differ in their capacity to bind factor H, suggesting that sequence variation within pspC reflects differences in biological function.
